| Symbol | NVCR |
|---|---|
| Name | NOVOCURE LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | NO. 4 THE FORUM, ST. HELIER, None None |
| Telephone | 44 (0)15 3475 6700 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001645113 |
| Description | None |
📋 NICOLAS LEUPIN (Officer) plans to sell 39K shares of NovoCure Limited (at $15.57 each, total $609K) Filed: Jul 23, 2026 | ID: 007278
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
Read more(10% Negative) NOVOCURE LTD (NVCR) Announces Delay in observed Trials for locally Due to Regulatory Process, Manufacturing Considerations, Safety Review
Read moreNovocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR
Read moreNVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm
Read more